Loading...

Thomson Medical Group

SGX:A50
Snowflake Description

Moderate growth potential with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
A50
SGX
SGD2B
Market Cap
  1. Home
  2. SG
  3. Healthcare
Company description

Thomson Medical Group Limited provides healthcare services for women and children primarily in Singapore. The last earnings update was 9 days ago. More info.


Add to Portfolio Compare Print
A50 Share Price and Events
7 Day Returns
1.3%
SGX:A50
-0.2%
SG Healthcare
0.4%
SG Market
1 Year Returns
-
SGX:A50
-15.9%
SG Healthcare
-5.9%
SG Market
A50 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Thomson Medical Group (A50) 1.3% -1.3% 1.3% - - -
SG Healthcare -0.2% -1.9% -2.7% -15.9% -28.6% 0.6%
SG Market 0.4% 3.3% 4.1% -5.9% 8.8% -2.5%
1 Year Return vs Industry and Market
  • No trading data on A50.
  • No trading data on A50.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Thomson Medical Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Thomson Medical Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Thomson Medical Group.

SGX:A50 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 7.8%
Perpetual Growth Rate 10-Year SG Government Bond Rate 2.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SGX:A50
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year SG Govt Bond Rate 2.3%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.715 (1 + (1- 17%) (28.9%))
0.924
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.92
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.3% + (0.924 * 5.96%)
7.81%

Discounted Cash Flow Calculation for SGX:A50 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Thomson Medical Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

SGX:A50 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (SGD, Millions) Source Present Value
Discounted (@ 7.81%)
2019 18.66 Est @ -8.38% 17.31
2020 17.69 Est @ -5.18% 15.22
2021 17.17 Est @ -2.93% 13.70
2022 16.94 Est @ -1.36% 12.54
2023 16.89 Est @ -0.26% 11.60
2024 16.98 Est @ 0.51% 10.81
2025 17.16 Est @ 1.05% 10.13
2026 17.40 Est @ 1.42% 9.53
2027 17.70 Est @ 1.69% 8.99
2028 18.03 Est @ 1.87% 8.50
Present value of next 10 years cash flows SGD118.34
SGX:A50 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= SGD18.03 × (1 + 2.3%) ÷ (7.81% – 2.3%)
SGD334.79
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= SGD334.79 ÷ (1 + 7.81%)10
SGD157.81
SGX:A50 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= SGD118.34 + SGD157.81
SGD276.15
Equity Value per Share
(SGD)
= Total value / Shares Outstanding
= SGD276.15 / 26,324.95
SGD0.01
SGX:A50 Discount to Share Price
Calculation Result
Value per share (SGD) From above. SGD0.01
Current discount Discount to share price of SGD0.08
= -1 x (SGD0.08 - SGD0.01) / SGD0.01
-634%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Thomson Medical Group is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Thomson Medical Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Thomson Medical Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SGX:A50 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in SGD SGD0.00
SGX:A50 Share Price ** SGX (2019-04-18) in SGD SGD0.08
Singapore Healthcare Industry PE Ratio Median Figure of 5 Publicly-Listed Healthcare Companies 27.12x
Singapore Market PE Ratio Median Figure of 328 Publicly-Listed Companies 13.07x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Thomson Medical Group.

SGX:A50 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SGX:A50 Share Price ÷ EPS (both in SGD)

= 0.08 ÷ 0.00

185.54x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Thomson Medical Group is overvalued based on earnings compared to the SG Healthcare industry average.
  • Thomson Medical Group is overvalued based on earnings compared to the Singapore market.
Price based on expected Growth
Does Thomson Medical Group's expected growth come at a high price?
Raw Data
SGX:A50 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 185.54x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
29.6%per year
Asia Healthcare Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Companies 1.76x
Singapore Market PEG Ratio Median Figure of 119 Publicly-Listed Companies 1.45x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Thomson Medical Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Thomson Medical Group's assets?
Raw Data
SGX:A50 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in SGD SGD0.03
SGX:A50 Share Price * SGX (2019-04-18) in SGD SGD0.08
Singapore Healthcare Industry PB Ratio Median Figure of 6 Publicly-Listed Healthcare Companies 2.6x
Singapore Market PB Ratio Median Figure of 432 Publicly-Listed Companies 0.75x
SGX:A50 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SGX:A50 Share Price ÷ Book Value per Share (both in SGD)

= 0.08 ÷ 0.03

2.81x

* Primary Listing of Thomson Medical Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Thomson Medical Group is overvalued based on assets compared to the SG Healthcare industry average.
X
Value checks
We assess Thomson Medical Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Thomson Medical Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Thomson Medical Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Thomson Medical Group, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
29.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Thomson Medical Group expected to grow at an attractive rate?
  • Thomson Medical Group's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
  • Thomson Medical Group's earnings growth is expected to exceed the Singapore market average.
  • Unable to compare Thomson Medical Group's revenue growth to the Singapore market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SGX:A50 Future Growth Rates Data Sources
Data Point Source Value (per year)
SGX:A50 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 29.6%
Singapore Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 14.4%
Asia Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 12.2%
Singapore Market Earnings Growth Rate Market Cap Weighted Average 5.6%
Singapore Market Revenue Growth Rate Market Cap Weighted Average 4.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SGX:A50 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in SGD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SGX:A50 Past Financials Data
Date (Data in SGD Millions) Revenue Cash Flow Net Income *
2018-12-31 216 41 11
2018-09-30 212 44 10
2018-06-30 208 51 14
2018-03-31 205 52 15
2017-12-31 201 52 16
2017-08-31 199 49 33
2016-08-31 193 44 27

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Thomson Medical Group's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Thomson Medical Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SGX:A50 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Thomson Medical Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SGX:A50 Past Financials Data
Date (Data in SGD Millions) EPS *
2018-12-31 0.00
2018-09-30 0.00
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.00
2017-08-31 327.95
2016-08-31 266.71

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Thomson Medical Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Thomson Medical Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Singapore market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Asia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Thomson Medical Group has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Thomson Medical Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Thomson Medical Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Thomson Medical Group's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Thomson Medical Group's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Thomson Medical Group's 1-year earnings growth is negative, it can't be compared to the SG Healthcare industry average.
Earnings and Revenue History
Thomson Medical Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Thomson Medical Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SGX:A50 Past Revenue, Cash Flow and Net Income Data
Date (Data in SGD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 215.61 10.84
2018-09-30 211.81 9.73
2018-06-30 208.47 13.74
2018-03-31 204.52 15.01
2017-12-31 200.58 16.27
2017-08-31 199.38 32.80 34.12
2016-08-31 193.29 26.67 34.03
2015-08-31 177.25 24.70 31.82

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Thomson Medical Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Thomson Medical Group used its assets less efficiently than the SG Healthcare industry average last year based on Return on Assets.
  • Thomson Medical Group's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Thomson Medical Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Thomson Medical Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Thomson Medical Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Thomson Medical Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Thomson Medical Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Thomson Medical Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Thomson Medical Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Thomson Medical Group Company Filings, last reported 3 months ago.

SGX:A50 Past Debt and Equity Data
Date (Data in SGD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 784.13 578.30 117.33
2018-09-30 792.60 587.75 120.79
2018-06-30 808.89 587.41 117.59
2018-03-31
2017-12-31 736.76 221.22 139.79
2017-08-31 357.69 547.03 114.80
2016-08-31 331.47 584.44 123.26
2015-08-31 281.17 612.44 118.82
  • Thomson Medical Group's level of debt (73.8%) compared to net worth is high (greater than 40%).
  • Unable to establish if Thomson Medical Group's debt level has increased without past 5-year debt data.
  • Debt is not well covered by operating cash flow (7%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.4x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Thomson Medical Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Thomson Medical Group has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Thomson Medical Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Thomson Medical Group dividends.
If you bought SGD2,000 of Thomson Medical Group shares you are expected to receive SGD0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Thomson Medical Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Thomson Medical Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SGX:A50 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Asia Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 27 Stocks 1.9%
Singapore Market Average Dividend Yield Market Cap Weighted Average of 278 Stocks 3.9%
Singapore Minimum Threshold Dividend Yield 10th Percentile 1.6%
Singapore Bottom 25% Dividend Yield 25th Percentile 2.5%
Singapore Top 25% Dividend Yield 75th Percentile 5.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Thomson Medical Group has not reported any payouts.
  • Unable to verify if Thomson Medical Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Thomson Medical Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Thomson Medical Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Thomson Medical Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Thomson Medical Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Thomson Medical Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Thomson Medical Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Roy Quek
TENURE AS CEO 1 years
CEO Bio

Mr. Hong Sheng Quek also known as Roy, has been the Chief Executive Officer and Director of Thomson Medical Group Ltd since April 25, 2018. Mr. Quek was appointed as Executive Director and Chief Executive Officer, Healthcare on 25 April 2018. He is an Executive Director and Group Chief Executive Officer of TMC Life Sciences Berhad since 2 June 2015. Mr Quek was a member of the Singapore Administrative Service and had served as Deputy Secretary in the Ministry of Health and in various capacities in the Ministry of Defence, Ministry of Education, Ministry of Community Development, Youth and Sports, Ministry of Health, Ministry of Home Affairs and the Prime Minister’s Office prior to joining the private sector. For his work in the Singapore public sector, he was conferred the Public Administration Medal (Silver) in 2008. Mr Quek also chairs the Board of Governors of St Joseph’s Institution International and serves on the Board of Directors of MediaCorp. Mr Quek received his undergraduate and postgraduate education at the London School of Economics and Peking University, respectively.

CEO Compensation
  • Insufficient data for Roy to compare compensation growth.
  • Insufficient data for Roy to establish whether their remuneration is reasonable compared to companies of similar size in Singapore.
Management Team Tenure

Average tenure of the Thomson Medical Group management team in years:

0.6
Average Tenure
  • The average tenure for the Thomson Medical Group management team is less than 2 years, this suggests a new team.
Management Team

Roy Quek

TITLE
CEO & Executive Director
TENURE
1 yrs

Wilson Sam

TITLE
Executive Director & Group CFO
TENURE
0.1 yrs

Zing Tan

TITLE
Chief Risk Officer & Director of Group Finance
TENURE
0.1 yrs

Chee Kien Seah

TITLE
Managing Director of RSP Architecture & Design

Teo Yann

TITLE
Managing Director of Squire Mech Mechanical & Electrical Engineering

Swee Chiew Beh

TITLE
Managing Director of RSP Civil & Structural Engineering

Hasan Malik bin Abdul Quddoos

TITLE
Joint Company Secretary

Foo Soon Soo

TITLE
Joint Secretary
TENURE
0.6 yrs

Lim Hoi Leong

TITLE
Joint Secretary
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the Thomson Medical Group board of directors in years:

1
Average Tenure
63
Average Age
  • The average tenure for the Thomson Medical Group board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ser Miang Ng

TITLE
Non-Executive Independent Chairman
AGE
68
TENURE
3.3 yrs

Roy Quek

TITLE
CEO & Executive Director
TENURE
1 yrs

Wilson Sam

TITLE
Executive Director & Group CFO
TENURE
0.1 yrs

Gary Ho

TITLE
Independent Director
AGE
63
TENURE
4.1 yrs

Pang Ong

TITLE
Independent Director
AGE
58
TENURE
3.3 yrs

Freddie Heng

TITLE
Non-Executive Non-Independent Director
TENURE
1 yrs

Wee Lim

TITLE
Non-Executive & Non-Independent Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (SGD) Value (SGD)
X
Management checks
We assess Thomson Medical Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Thomson Medical Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What does Thomson Medical Group Limited's (SGX:A50) Balance Sheet Tell Us About Its Future?

While small-cap stocks, such as Thomson Medical Group Limited (SGX:A50) with its market cap of S$2.1b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Who Are The Largest Shareholders In Rowsley Ltd (SGX:A50)?

In this article, I'm going to take a look at Rowsley Ltd’s (SGX:A50) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … A company's ownership structure is often linked to its share performance in both the long- and short-term. … Although this is an important factor for long-term investors, many investors can also be impacted by institutional presence and their high-volume trading.

Simply Wall St -

Should You Be Concerned About Thomson Medical Group Limited's (SGX:A50) Investors?

I am going to take a deep dive into Thomson Medical Group Limited’s (SGX:A50) most recent ownership structure, not a frequent subject of discussion among individual investors. … See our latest analysis for Thomson Medical Group SGX:A50 Ownership_summary May 10th 18 Insider Ownership Insiders form another group of important ownership types as they manage the company's operations and decide the best use of capital. … General Public Ownership The general public holds 7.47% stake in A50, thus, representing an important class of owners.

Simply Wall St -

How Rowsley Ltd (SGX:A50) Can Impact Your Portfolio Volatility

Check out our latest analysis for Rowsley An interpretation of A50's beta Rowsley’s beta of 0.75 indicates that the company is less volatile relative to the diversified market portfolio. … Based on this beta value, A50 appears to be a stock that an investor with a high-beta portfolio would look for to reduce risk exposure to the market. … However, this is the opposite to what A50’s actual beta value suggests, which is lower stock volatility relative to the market.

Simply Wall St -

How Financially Strong Is Rowsley Ltd (SGX:A50)?

On top of this, A50 has produced cash from operations of S$272.00K over the same time period, leading to an operating cash to total debt ratio of 0.22%, indicating that A50’s operating cash is not sufficient to cover its debt. … Looking at A50’s most recent S$141.62M liabilities, it appears that the company has maintained a safe level of current assets to meet its obligations, with the current ratio last standing at 1.66x. … Risk around debt is very low for A50, and the company also has the ability and headroom to increase debt if needed going forward.Next Steps: Although A50’s debt level is relatively low, its cash flow levels still could not copiously cover its borrowings.

Simply Wall St -

Has Rowsley Ltd (SGX:A50) Improved Earnings Growth In Recent Times?

In this commentary, I will examine Rowsley Ltd's (SGX:A50) latest earnings update (31 December 2017) and compare these figures against its performance over the past couple of years, as well as how the rest of the professional services industry performed. … Check out our latest analysis for Rowsley Commentary On A50's Past Performance For the most up-to-date info, I use the ‘latest twelve-month’ data, which either annualizes the most recent 6-month earnings update, or in some cases, the most recent annual report is already the latest available financial data. … This means that, Rowsley has historically performed better than recently, while it seems like earnings are now heading back towards a more favorable position once more.

Simply Wall St -

What Is The Future Prospect For Service And Rowsley Ltd (SGX:A50)?

Rowsley Ltd (SGX:A50), a $611.26M small-cap, operates in the professional services industry, whose performance is linked to business conditions and the general economy, as it draws revenue from industries across different sectors. … Professional services analysts are forecasting for the entire industry, a positive double-digit growth of 13.01% in the upcoming year , and a strong near-term growth of 22.50% over the next couple of years. … Next Steps: Rowsley has been a professional services industry laggard in the past year.

Simply Wall St -

Who Are The Top Investors In Rowsley Ltd (SGX:A50)?

In this article, I'm going to take a look at Rowsley Ltd’s (SGX:A50) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … With this size of ownership, retail investors can collectively play a role in major company policies that affect shareholders returns, including executive remuneration and the appointment of directors. … What this means for you: Institutional ownership level and composition in A50 is not high nor active enough to significantly impact its investment thesis.

Simply Wall St -

Does Rowsley Ltd (SGX:A50) Have Enough Money Left To Grow?

Check out our latest analysis for Rowsley What is cash burn? … My cash burn analysis suggests that, if Rowsley continues to spend its cash reserves at this current high rate, it’ll have to raise capital within the next 8 months, which may be a surprise to some shareholders. … The cash burn analysis result indicates a cash constraint for the company, due to its high opex growth and its level of cash reserves.

Simply Wall St -

Can Rowsley Ltd (SGX:A50) Improve Your Portfolio Returns?

Rowsley's beta of 0.75 indicates that the stock value will be less variable compared to the whole stock market. … Based on this beta value, A50 appears to be a stock that an investor with a high-beta portfolio would look for to reduce risk exposure to the market. … This is an interesting conclusion, since both A50’s size and industry indicates the stock should have a higher beta than it currently has.

Simply Wall St -

Company Info

Description

Thomson Medical Group Limited provides healthcare services for women and children primarily in Singapore. The company owns and operates the Thomson Medical Center, and a network of 34 clinics and centers, which provide services in the areas of obstetrics and gynecology, pediatric, dermatology, aesthetic, sports medicine, wellness, and cardiology, as well as other consumer business segment. It also operates specialized clinics and centers, such as women's clinics, as well as pediatric, fertility, women cancer, cardiology, Chinese medicine, and skin centers under the Thomson name; and provides consumer products. In addition, the company engages in the operation of a pre-natal and clinical diagnostic laboratory; the Tropicana Medical Center with 205 beds located in Kota Damansara, Kuala Lumpur; the TMC Fertility Center that offers a range of fertility treatment options for male and female patients in Malaysia; and the Thomson Iskandar Medical Hub, as well as the Vantage Bay Healthcare City, an integrated health and wellness development that consists of medical, wellness, and educational facilities in Iskandar Malaysia. Further, it is involved in multi-disciplinary real estate business that encompasses design and engineering, hospitality, and property development and investment. The company’s design and engineering business includes RSP Architects Planners & Engineers, an architectural practice in architecture, engineering, master planning, urban design, and interior design. It also operates Squire Mech, a mechanical and electrical engineering consultancy; and AC Consortium, which specializes in the design of industrial buildings. The company’s hospitality businesses comprise Hotel Football, Cafe Football, and Stock Exchange Hotel; and GG Hospitality and Ariva Hospitality, which provide hospitality management services in the United Kingdom and Asia respectively. Thomson Medical Group Limited was founded in 1999 and is based in Singapore.

Details
Name: Thomson Medical Group Limited
A50
Exchange: SGX
Founded: 1999
SGD2,000,696,195
26,324,949,945
Website: http://www.thomsonmedicalgroup.com
Address: Thomson Medical Group Limited
1 Kallang Junction,
No. 03-01,
Singapore,
339263,
Singapore
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SGX A50 Ordinary Shares Singapore Exchange SG SGD 26. Apr 2018
Number of employees
Current staff
Staff numbers
1,478
Thomson Medical Group employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 13:09
End of day share price update: 2019/04/18 00:00
Last earnings filing: 2019/04/09
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.